Cargando…
Efficacy of Switching from Kanamycin Sulfate to Rifaximin in Patients with Hepatic Cirrhosis
OBJECTIVE: This study evaluated the efficacy associated with switching to rifaximin in patients with hepatic cirrhosis receiving kanamycin sulfate for the treatment of hepatic encephalopathy and hyperammonemia. METHODS: We included 37 patients who switched from kanamycin sulfate to rifaximin at our...
Autores principales: | Tatsumi, Ryoji, Suii, Hirokazu, Yamaguchi, Masakatsu, Arakawa, Tomohiro, Nakajima, Tomoaki, Kuwata, Yasuaki, Toyota, Joji, Hige, Shuhei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8188012/ https://www.ncbi.nlm.nih.gov/pubmed/33361677 http://dx.doi.org/10.2169/internalmedicine.6039-20 |
Ejemplares similares
-
Safety of Sofosbuvir and Ribavirin Combination Therapy in a Patient Who Developed Anemia due to Ribavirin
por: Suii, Hirokazu, et al.
Publicado: (2017) -
Zinc deficiency in patients with chronic liver disease in Japan
por: Ozeki, Itaru, et al.
Publicado: (2020) -
The Use of Rifaximin in Patients With Cirrhosis
por: Caraceni, Paolo, et al.
Publicado: (2021) -
Telaprevir impairs renal function and increases blood ribavirin concentration during telaprevir/pegylated interferon/ribavirin therapy for chronic hepatitis C
por: Karino, Y, et al.
Publicado: (2014) -
Rifaximin as a rare cause of rhabdomyolysis in cirrhosis
por: Rezigh, Alec B., et al.
Publicado: (2018)